| Name | Title | Contact Details |
|---|
Valley Medical Center (VMC), also known as King County Public Hospital District No. 1, is located in Renton, WA. The Medical Center’s service area includes the communities of Renton, Kent, Tukwila, Covington, Maple Valley, Auburn, Newcastle and the surrounding environs. A 303-bed acute care hospital and clinic network, VMC is committed to providing safe, quality compassionate care and has done so for more than 63 years. Seattle magazine named VMC the #1 non-profit in the state for 2011, the Puget Sound Business Journal honored VMC as “Washington’s Best Workplace” for 2011 in the extra large company category, and for ten consecutive years VMC has been named a “Best Workplace” by regional publications. For the past four out of four years VMC has been named a “Best Place to Work in Healthcare” in the nation by Modern Healthcare magazine, including twice achieving a top 10 ranking. Valley Medical Center is a component entity of UW Medicine.
Assured Space Access Technologies is a company that provides engineering services to the Aerospace Industry, with specific focus on defense space systems. They specialize in Satellite System Design, Assembly, Integration and Test Engineering, Analysis,...
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
iCarbonX is building a digital life ecosystem by combining consumer life data, the Internet and artificial intelligence.
SouthLight Healthcare is a nonprofit organization that provides outpatient and community-based services for mental health and substance use treatment. They empower the journey through prevention, education, and innovative treatment solutions delivered ...